April 16th 2024
The 5-in-1 vaccine candidate has the potential to reduce shots and simplify the immunization process.
ISV congress offers vaccine updates and information on hypersensitivity
June 4th 2021The last meeting of the COVID-19 vaccine congress from the International Society for Vaccines (ISV) provided information on the hypersensitivity events tied to mRNA vaccines as well as the most recent information on the Janssen and Novavax vaccines.
Improving HPV vaccine rates by training clinicians
May 27th 2021The human papillomavirus (HPV) vaccine is a key intervention for a number of cancers, but the opportunity to discuss the vaccine is missed all too often. Could an online educational program help clinicians improve their HPV vaccine communication strategies?
ACOG advisory offers latest info for COVID-19 vaccine use in pregnant and lactating patients
May 21st 2021A recently updated Practice Advisory from the American College of Obstetricians and Gynecologists (ACOG) provides an overview of the latest guidance for COVID-19 vaccination in pregnant and lactating patients.
NASPAG discusses COVID-19 vaccines and gynecological care considerations for teens and young adults
May 17th 2021Eligible children and teens should receive COVID-19 vaccination to protect them from COVID-19 infection, as well as to reduce the spread of the virus in the community and to vulnerable people, according to the statement from the North American Society for Pediatric and Adolescent Gynecology (NASPAG) .
AAP letter urges the start of COVID-19 vaccine trials in young children
February 26th 2021A safe coronavirus 2019 disease (COVID-19) vaccine that can be administered to most of the pediatric population is a necessity for ending the pandemic, but trials for younger children have not occurred. The president of the American Academy of Pediatrics (AAP) wrote to key COVID-19 officials about the need to change this.
Are primary prevention strategies altering the course of the perfect storm?
February 23rd 2021As the 2020-2021 influenza season loomed, many in health care worried that the seasonal disease would add to the extraordinary burden of coronavirus disease 2019 and create a perfect storm. Have various prevention strategies helped prevent this potential issue?
Pfizer COVID-19 vaccine receives emergency use authorization
December 14th 2020Following the green light from the vaccine advisory committee, the US Food and Drug Administration has given emergency use authorization for the Pfizer/BioNTech COVID-19 vaccine, making it the first vaccine for COVID-19 approved for use in the United States.